Literature DB >> 9199642

A comparative study of pure tubular and tubulolobular carcinoma of the breast.

I Green1, B McCormick, M Cranor, P P Rosen.   

Abstract

Tubular carcinoma is a distinctive subtype of invasive, well-differentiated mammary ductal carcinoma that has a good prognosis when treated by modified radical mastectomy. Little is known about tubulolobular carcinoma. The purpose of this study was to compare the frequency of prognostic factors in pure tubular carcinoma (PTC) and tubulolobular carcinoma (TLC). We studied 90 cases of pure PTC and 17 cases of TLC. The following results were found for PTC: size 0.5 to 1.8 cm (mean, 1.2 cm); multifocality in 18 of 90 cases (20%); axillary lymph-node dissection performed in 51 patients; positive axillary lymph nodes in six of 51 cases (12%); recurrences in one of 90 cases (1%), local. The following results were found for TLC: size 0.6 to 2 cm (mean, 1.3 cm); multifocality in five of 17 cases (29%); axillary lymph-node dissection performed in 14 patients; positive axillary lymph nodes in six of 14 cases (43%); recurrences in two of 17 cases (12%); one local and one systemic, each after mastectomy. The relationship between multifocality and positive axillary lymph nodes was as follows: In PTC, the percentage of positive axillary lymph nodes in multifocal cases was 33%, and in nonmultifocal cases, 7%; in TLC, the percentage of positive axillary lymph nodes in multifocal cases was 60% and in nonmultifocal cases, 33%. In conclusion, multifocality and positive axillary lymph nodes were more frequent in TLC than in PTC. Multifocality appeared to predispose to positive lymph nodes in both PTC and TLC. The distribution of prognostic factors suggest that TLC is a higher-grade lesion than PTC. Long-term follow-up is needed to correlate multifocality with recurrence after breast conserving therapy.

Entities:  

Mesh:

Year:  1997        PMID: 9199642     DOI: 10.1097/00000478-199706000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

Review 1.  [Lobular neoplasms and invasive lobular breast cancer].

Authors:  H-P Sinn; B Helmchen; J Heil; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

2.  Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.

Authors:  Hajime Kuroda; Jun-Ichi Tamaru; Ikuya Takeuchi; Kiyoshi Ohnisi; Goi Sakamoto; Akiko Adachi; Kou Kaneko; Shinji Itoyama
Journal:  Virchows Arch       Date:  2006-03-15       Impact factor: 4.064

3.  Established breast cancer risk factors by clinically important tumour characteristics.

Authors:  M García-Closas; L A Brinton; J Lissowska; N Chatterjee; B Peplonska; W F Anderson; N Szeszenia-Dabrowska; A Bardin-Mikolajczak; W Zatonski; A Blair; Z Kalaylioglu; G Rymkiewicz; D Mazepa-Sikora; R Kordek; S Lukaszek; M E Sherman
Journal:  Br J Cancer       Date:  2006-06-06       Impact factor: 7.640

4.  Clinicopathologic characteristics and clinical outcomes of pure type and mixed type of tubular carcinoma of the breast: a single-institution cohort study.

Authors:  Wen-Wen Zhang; San-Gang Wu; Yi-Hong Ling; Jia-Yuan Sun; Zhi-Qing Long; Xin Hua; Yong Dong; Feng-Yan Li; Zhen-Yu He; Huan-Xin Lin
Journal:  Cancer Manag Res       Date:  2018-10-11       Impact factor: 3.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.